These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 21273510)
1. Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary. Uzan C; Kane A; Rey A; Gouy S; Camatte S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P Oncologist; 2011; 16(2):189-96. PubMed ID: 21273510 [TBL] [Abstract][Full Text] [Related]
2. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern. Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973 [TBL] [Abstract][Full Text] [Related]
3. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Prat J; De Nictolis M Am J Surg Pathol; 2002 Sep; 26(9):1111-28. PubMed ID: 12218568 [TBL] [Abstract][Full Text] [Related]
4. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases. Deavers MT; Gershenson DM; Tortolero-Luna G; Malpica A; Lu KH; Silva EG Am J Surg Pathol; 2002 Sep; 26(9):1129-41. PubMed ID: 12218569 [TBL] [Abstract][Full Text] [Related]
5. Micropapillary pattern in serous borderline ovarian tumors: does it matter? Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH Gynecol Oncol; 2011 Dec; 123(3):511-6. PubMed ID: 21917305 [TBL] [Abstract][Full Text] [Related]
6. Outcome of patients with advanced-stage borderline ovarian tumors after a first peritoneal noninvasive recurrence: impact on further management. Uzan C; Zanini-Grandon AS; Bentivegna E; Gouy S; Leary A; Duvillard P; Morice P Int J Gynecol Cancer; 2015 Jun; 25(5):830-6. PubMed ID: 25828751 [TBL] [Abstract][Full Text] [Related]
7. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Eichhorn JH; Bell DA; Young RH; Scully RE Am J Surg Pathol; 1999 Apr; 23(4):397-409. PubMed ID: 10199469 [TBL] [Abstract][Full Text] [Related]
8. Results after conservative treatment of serous borderline tumours of the ovary with stromal microinvasion but without micropapillary pattern. Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P BJOG; 2009 May; 116(6):860-2. PubMed ID: 19432576 [TBL] [Abstract][Full Text] [Related]
9. Behavior of serous borderline ovarian tumors with and without micropapillary patterns: results of a French multicenter study. Fauvet R; Demblocque E; Morice P; Querleu D; Daraï E Ann Surg Oncol; 2012 Mar; 19(3):941-7. PubMed ID: 21879267 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary. Uzan C; Muller E; Kane A; Rey A; Gouy S; Bendiffallah S; Duvillard P; Fauvet R; Darai E; Morice P Ann Oncol; 2014 Jan; 25(1):166-71. PubMed ID: 24287939 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants. Kane A; Uzan C; Rey A; Gouy S; Camatte S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P Oncologist; 2009 Jun; 14(6):591-600. PubMed ID: 19487334 [TBL] [Abstract][Full Text] [Related]
12. Long term follow-up of a large series of stage-II/III atypical proliferative serous ovarian tumors. Maria S; Faron M; Maulard A; Pautier P; Leary A; Chargari C; Genestie C; Gouy S; Morice P Gynecol Oncol; 2020 Sep; 158(3):659-665. PubMed ID: 32571680 [TBL] [Abstract][Full Text] [Related]
13. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Silva EG; Gershenson DM; Malpica A; Deavers M Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075 [TBL] [Abstract][Full Text] [Related]
14. A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component. Slomovitz BM; Caputo TA; Gretz HF; Economos K; Tortoriello DV; Schlosshauer PW; Baergen RN; Isacson C; Soslow RA Am J Surg Pathol; 2002 May; 26(5):592-600. PubMed ID: 11979089 [TBL] [Abstract][Full Text] [Related]
15. Fertility results and outcomes after pure laparoscopic management of advanced-stage serous borderline tumors of the ovary. Kane A; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P Fertil Steril; 2010 Dec; 94(7):2891-4. PubMed ID: 20537629 [TBL] [Abstract][Full Text] [Related]
16. Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary. Uzan C; Kane A; Rey A; Gouy S; Duvillard P; Morice P Ann Oncol; 2010 Jan; 21(1):55-60. PubMed ID: 19608617 [TBL] [Abstract][Full Text] [Related]
17. [Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy]. Mecke H; Börner-Klaussner B; Grosse G; Nadjari B; Hauptmann S Zentralbl Gynakol; 2000; 122(5):274-9. PubMed ID: 10857214 [TBL] [Abstract][Full Text] [Related]
18. Clinical Predictors of Recurrence and Prognostic Value of Lymph Node Involvement in the Serous Borderline Ovarian Tumor. Qian XQ; Hua XP; Wu JH; Shen YM; Cheng XD; Wan XY Int J Gynecol Cancer; 2018 Feb; 28(2):279-284. PubMed ID: 29194193 [TBL] [Abstract][Full Text] [Related]
19. Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors. Vancraeynest E; Moerman P; Leunen K; Amant F; Neven P; Vergote I Int J Gynecol Cancer; 2016 Oct; 26(8):1399-406. PubMed ID: 27465897 [TBL] [Abstract][Full Text] [Related]
20. Autoimplants in serous borderline tumors of the ovary: a clinicopathologic study of 30 cases of a process to be distinguished from serous adenocarcinoma. Rollins SE; Young RH; Bell DA Am J Surg Pathol; 2006 Apr; 30(4):457-62. PubMed ID: 16625091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]